MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.
One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...
It's true Oura partners with Palantir Technologies, a software company that serves the U.S. government. But some claims about data-sharing are false.
One of the Apple Watch’s biggest threats has no screen, weighs about a fifth of an ounce and charges a monthly subscription for most of its features. Yet the Oura ring is on pace for $1 billion in ...
As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...
A few months earlier, Bluestein suffered an injury to her ACL, meniscus and labrum, which forced her to sit out for an ...
Investor's Business Daily on MSN
Stock market today: S&P 500, Dow up, gold miners jump; AI stocks brush off Oracle drop (live coverage)
Outside the Dow, ATI ATI led the upside among aerospace industry stocks. The specialist in metal alloys used in plane production gained 2% in the early going and hit a morning session high of 107.27.
Johnson & Johnson Medtech announced the expansion of its Research, Development, and Innovation (RD&I) activities at its ...
Neither had a great year in 2025, but the future is looking bright.
A retired lawyer lost the money in a tech support scam, a type of online fraud that is surging. Citibank said it couldn’t recover the funds, which criminals wired from inside his account. David Welles ...
Senseonics earns a buy with Eversense 365 driving growth, Q3 revenue up 90% YoY, gross margin expansion, and Ascensia integration. Read why SENS stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results